Skip to main content

Month: July 2024

Superior Medical Waste Disposal Acquires Bioclean Team Inc.’s Medical Waste Customer Base

Expanding Reach and Enhancing Services for Michigan Healthcare ProfessionalsSuperior Medical Waste Disposal and Bio Clean TeamSuperior Medical Waste Disposal and Bio Clean Team’s Vision for Health and Safety.DETROIT, July 09, 2024 (GLOBE NEWSWIRE) — Superior Medical Waste Disposal, a leading healthcare waste service provider founded in 2009, is proud to announce the acquisition of Bioclean Team Inc.’s medical waste customer base. This strategic move strengthens Superior’s commitment to delivering top-notch medical waste disposal services across Michigan and the Midwest region. Superior Medical Waste Disposal specializes in the safe and efficient removal of sharps containers and biohazard waste from a variety of healthcare facilities. By integrating Bioclean Team Inc.’s medical waste clients, Superior...

Continue reading

Ascot Resources Announces Increase to Previously Announced Bought Deal Offering to C$29 Million

Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company“) is pleased to announce that due to strong demand, it has increased the size of the previously announced public offering of flow-through units (the “Flow-Through Units”) to 30,242,000 Flow-Through Units at a price of C$0.496 per Flow-Through Unit and of hard dollar units (the “HD Units”) to 32,560,000 HD Units at a price of C$0.43 per HD Unit (together, the “Offered Securities”) for gross proceeds of approximately C$29 million (the “Offering”). In connection therewith, the Company has entered into an amended agreement with a syndicate of underwriters led by BMO Capital Markets and Desjardins...

Continue reading

ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy

Framework to determine stimulation parameters for ONWARD ARC-EX Therapy are published in the journal Neuromodulation: Technology at the Neural Interface Peer-reviewed publication is based on results from the Up-LIFT and LIFT Home studies EINDHOVEN, the Netherlands, July 09, 2024 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces a publication in Neuromodulation: Technology at the Neural Interface, summarizing effective stimulation parameters from the Up-LIFT and LIFT Home studies and providing a decision-making framework for clinical implementation of ONWARD ARC-EX Therapy created by study investigators. Investigational ARC-EX Therapy...

Continue reading

Neon Bloom Changes Course With New Leadership and Divestment of Bazelet™

Recent Acquisition Leads to New Management and Expanding Focus On Financial Services Sector NEWPORT BEACH, Calif., July 09, 2024 (GLOBE NEWSWIRE) — Neon Bloom, Inc. (OTC PINK: NBCO), announced today that it has divested itself of its subsidiary, Bazelet™ Health Systems Inc. in a shift in the Company’s direction away from the HealthTech sector following the acquisition of Advanced Executive Sales, LLC (AES). Following the acquisition of AES, the Company added an additional Director, Mr. Anthony Bianchi Esq., who will replace Ms. Frick who resigned in 2023 and will be serving as an Independent Director. Mr. Bianchi is currently a practicing lawyer and will not be taking an active management position in the Company at this time; he will join Mr. Fred Luke and Mr. Greg Bauer, the Company’s new CEO, on the Company’s Board of...

Continue reading

DÉKUPLE announces the acquisition of Ereferer, an automated netlinking platform, by Rocket Marketing

DÉKUPLE announces the acquisition of Ereferer, an automated netlinking platform, by Rocket Marketing Paris, 9 July 2024 (6.30pm) – The DÉKUPLE Group, a cross-channel data marketing expert, announces that its subsidiary Rocket Marketing has acquired 100% of the capital of Ereferer, an innovative platform specialising in automated netlinking. This strategic acquisition will enable Rocket Marketing to strengthen its offering in the Brand Content and, more specifically, Netlinking market. Launched in 2014, Ereferer is an automated netlinking platform dedicated to optimizing digital marketing strategies through the most affordable and comprehensive self-service solutions available on the market. With over 65,000 blogs and media referenced, Ereferer’s French and international catalogue enables any advertiser, regardless of their...

Continue reading

Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”

Ambassador Frank Wisner To Join Vyome Board Of Directors CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) — Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, announced today that it has signed a merger agreement with ReShape Lifesciences (Nasdaq: RSLS). Upon closing, it is anticipated that the post-merger entity, will be renamed Vyome Holdings, Inc., and continue to have its common stock traded on Nasdaq under the new ticker symbol “HIND”, an ancient name for India, an integral part of Vyome’s identity. Anchored in part by Dr. Ranjan Pai, Chairman of the Manipal Education and Medical Group (MEMG), and investors affiliated with Remus Capital and Iron Pillar, certain of the Company’s stockholders have, simultaneously with...

Continue reading

Total number of shares and voting rights at June 30, 2024

9 July 2024 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years.Date Number of shares Number of treasury shares without voting rights Theoretical number of voting rights [1] Number of voting rights exercisable01/31/2024 2, 660, 056,599 2, 014,145 3, 154, 643,135 3 152, 628,99002/29/2024 2, 660, 056,599 1, 874,145 3, 154, 554,054 3, 152, 679,90903/31/2024 2, 660, 056,599 1, 770,145 3,...

Continue reading

IPSEN – Buy-back programme – Art 5 of MAR – Week 27 – 2024

Aggregated presentation by day and by marketPurchases of own shares from July 1st to 5th 2024             Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code)IPSEN 549300M6SGDPB4Z94P11 01/07/2024 FR0010259150 4 400 114,6643 XPARIPSEN 549300M6SGDPB4Z94P11 01/07/2024 FR0010259150 1 600 114,6941 CEUXIPSEN 549300M6SGDPB4Z94P11 02/07/2024 FR0010259150 5 000 113,7584 XPARIPSEN 549300M6SGDPB4Z94P11 02/07/2024 FR0010259150 2 000 113,7221 CEUXIPSEN 549300M6SGDPB4Z94P11 03/07/2024 FR0010259150 9 372 112,9871 XPARIPSEN 549300M6SGDPB4Z94P11 03/07/2024 FR0010259150 4 093 112,9235 CEUXIPSEN 549300M6SGDPB4Z94P11 03/07/2024 FR0010259150 300 112,6383 TQEXIPSEN 549300M6SGDPB4Z94P11 03/07/2024 FR0010259150 235 112,5774 AQEUIPSEN 549300M6SGDPB4Z94P11 04/07/2024 FR0010259150 7...

Continue reading

Report on Carbios’ liquidity contract with Natixis ODDO BHF

PRESS RELEASE   REGULATED INFORMATION: ONGOING Report on Carbios’ liquidity contract with Natixis ODDO BHFShares concerned: Carbios (ISIN code: FR0011648716) Market concerned: Euronext Growth ParisClermont-Ferrand (France), 09 July 2024 (18:00 CEST). CARBIOS, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, reports today about the liquidity contract entrusted to Natixis ODDO BHF. As of June 30, 2024, the following assets appeared on the liquidity account:18,236 shares € 199,349.87 Number of executions on buy side during the semester: 2,971 Number of executions on sell side during the semester: 2,909 Traded volume on buy side during the semester: 236,636 shares for € 5,531,493.24 Traded volume on sell side during the semester:...

Continue reading

Fly Play hf.:  Jónína Guðmundsdóttir Resigns from PLAY Airlines  

   Jónína Guðmundsdóttir Resigns from PLAY Airlines     Jónína Guðmundsdóttir has decided to resign as Chief People Officer of PLAY Airlines. She will remain in the position until the end of July. Jóna Björk Sigurjónsdóttir, Director of HR, will take over Jónína’s duties until further notice.     “Jónína has been one of PLAY’s key players since its inception. She has been the driving force in creating and developing a positive work culture based on strong values. Jónína has overseen the hiring of a company that now boasts around 550 employees. The company is well-positioned for the future thanks to the values she instilled. I want to thank Jónína for her contributions and wish her all the best in her future endeavors,” said Einar Örn Ólafsson, PLAY’s CEO.     “It has been an absolute privilege to get PLAY started....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.